Karamfilova, V. et al. 2022. Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease. Turkish Journal of Gastroenterology. 33, 3 (Jan. 2022), 233–239. DOI:https://doi.org/10.5152/tjg.2021.201165.